Utilities Registry – Center for Health Decision Science

Filter results using search terms, or by selecting one or more valuation, condition, or population.

Valuation

Population

Condition

Viewing 1 - 10 of 44 results

Title	Year(s) of data collection	Valuation Method	Country	Condition
Selection of autoimmune disease health state utilities (He A, Spelman T et al., J Neurol Neurosurg Psychiatry. 2023. doi:10.1136/jnnp-2022-330169)	2001 - 2020	EQ-5D-3L	Sweden	Multiple sclerosis
DOI 10.7910/DVN/XTLOGB Author(s) Registry, Utilities Description Health state utilities for autoimmune disease conditions Sample Characteristics 690 adults with relapsing multiple sclerosis in a Swedish registry to examine the association between early treatment of multiple sclerosis and patient-reported outcomes
Title Selection of mental health health state utilities (Stolz M et al., Eur J Health Econ. 2022. doi:10.1007/s10198-022-01543-w)	Year(s) of data collection 2008 - 2013	Valuation Method EQ-5D-3L, SF-6D	Country Germany	Condition Depression
DOI 10.7910/DVN/QNA5ZF Author(s) Registry, Utilities Description Health state utilities for mental health conditions Sample Characteristics 566 cardiac patients with depressive symptoms as part of the SPIRRCAD (Stepwise Psychotherapy Intervention for Reducing Risk in Coronary Artery Disease) trial
Title Selection of neurological disease health state utilities (Janssen N et al., J Alzheimers Dis. 2022. doi:10.3233/JAD-215304)	Year(s) of data collection 2009 - 2011	Valuation Method SF-6D	Country Finland	Condition Cognitive decline
DOI 10.7910/DVN/VJSSSX Author(s) Registry, Utilities Description Health state utilities for neurological disease conditions Sample Characteristics 1120 participants with longitudinal 2-year data from the FINGER study to investigate the association between cognition, health related quality of life, and costs in a population at risk for cognitive decline
Title Selection of oncology health state utilities (Konara Mudiyanselage SP et al., Breast Cancer. 2023. doi:10.1007/s12282-022-01413-6)	Year(s) of data collection 2010 - 2021	Valuation Method EQ-5D	Country Taiwan (Province of China)	Condition Breast cancer surgery
DOI 10.7910/DVN/L4V2LU Author(s) Registry, Utilities Description Health state utilities for oncology conditions Sample Characteristics A cohort of 741 women who underwent a mastectomy and breast reconstruction
Title Selection of neurological disease health state utilities (Lacy B et al., Clin Park Relat Disord. 2023. doi:10.1016/j.prdoa.2022.100180)	Year(s) of data collection 2010 - 2011	Valuation Method EQ-5D	Country United States of America	Condition Parkinson's disease
DOI 10.7910/DVN/VJSSSX Author(s) Registry, Utilities Description Health state utilities for neurological disease conditions Sample Characteristics A cross-sectional study of 124 patients with PD at an academic movement clinic
Title Selection of autoimmune disease health state utilities (Mitsikostas DD et al., Adv Ther. 2023. doi:10.1007/s12325-022-02388-8)	Year(s) of data collection 2012 - 2016	Valuation Method EQ-5D-3L	Country Greece	Condition Multiple sclerosis
DOI 10.7910/DVN/XTLOGB Author(s) Registry, Utilities Description Health state utilities for autoimmune disease conditions Sample Characteristics A prospective observational study of 458 participants under treatment with fingolimod conducted by hospital-based and private practice neurologists
Title Selection of orthopedic and musculoskeletal health state utilities (Panzram B et al., J Clin Med. 2023. doi:10.3390/jcm12041694)	Year(s) of data collection 2012 - 2016	Valuation Method EQ-5D-3L	Country Germany	Condition Knee replacement
DOI 10.7910/DVN/VR4XYO Author(s) Registry, Utilities Description Health state utilities for orthopedic and musculoskeletal conditions Sample Characteristics 201 participants in a retrospective single-center cohort study of patients who underwent cementless OUKR to investigate the clinical and functional results of cementless unicompartmental knee arthroplasty with a minimum follow up of 5 years
Title Selection of orthopedic and musculoskeletal health state utilities (Li N et al., J Med Econ. 2022. doi:10.1080/13696998.2022.2087409)	Year(s) of data collection 2014 - 2016	Valuation Method EQ-5D-5L, SF-6D	Country Netherlands	Condition Fracture
DOI 10.7910/DVN/VR4XYO Author(s) Registry, Utilities Description Health state utilities for orthopedic and musculoskeletal conditions Sample Characteristics 499 participants in a prospective observational study in a Dutch Fracture Liaison Service clinic
Title Selection of orthopedic and musculoskeletal health state utilities (Zhou AK et al., Eur J Orthop Surg Traumatol. 2023. doi:10.1007/s00590-022-03204-3)	Year(s) of data collection 2014 - 2021	Valuation Method EQ-5D-5L	Country United Kingdom of Great Britain and Northern Ireland	Condition Open talus fractures
DOI 10.7910/DVN/VR4XYO Author(s) Registry, Utilities Description Health state utilities for orthopedic and musculoskeletal conditions Sample Characteristics 14 participants from the review of electronic hospital records, cohort
Title Selection of oncology health state utilities (Yang M et al., Value Health. 2023. doi:10.1016/j.jval.2023.02.00)	Year(s) of data collection 2016 - 2021	Valuation Method EQ-5D-5L	Country Austria, Belgium, China, France, Germany, Israel, Italy, Japan, Korea (Republic of), Netherlands, Poland, Spain, Switzerland, Taiwan (Province of China), United States of America	Condition Lung cancer
DOI 10.7910/DVN/L4V2LU Author(s) Registry, Utilities Description Health state utilities for oncology conditions Sample Characteristics 273 patients with non-small cell lung cancer harboring MET exon 14 skipping treated with tepotinib

Next results →